Sponsor study identifier
interventional
22
1 country
1
Study Start
December 2012
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
August 2015
Actual (reported)Study Completion
August 2015
Actual (reported)Port wine stain Birthmark is a congenital, progressive vascular malformation of human skin. However, even though the pulsed dye laser is considered as the treatment of choice for Port wine stain Birthmark the degree of fading can remain variable and unpredictable after laser treatment.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 2015
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 2012
Date type not reportedThis date has not been verified as actual or estimated.
January 14, 2013
Actual (reported)January 25, 2013
Actual (reported)August 2015
Actual (reported)August 2015
Actual (reported)April 9, 2018
Actual (reported)Percent Change in Blanching of Port Wine Stain
Port Wine Stain blood volume fractions in the skin before (fB1), and 8 weeks after (fB2) treatment will be determined using the corresponding visual reflectance spectra measured at the treatment sites. The primary outcome, degree of blanching, B, is computed as B = (fB1-fB2)/fB1.
8 weeks
port wine stain treatment using Pulse Dye Laser
Port wine stain using Combined Bipolar Radiofrequency\&Pulsed Dye Laser
port wine stain
Combined Bipolar Radiofrequency\&Pulsed Dye Laser Treatment
Beckman Laser Institute Medical Clinic
Irvine, California, 92612, United States
J. Stuart Nelson, M.D., Ph.D.
Beckman Laser Institute, UCI
22 participants (actual enrollment reported by the registry).
First Submitted
January 14, 2013
First Posted
January 25, 2013
Study Start
December 2012
Date type not reportedThis date has not been verified as actual or estimated.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
August 2015
Actual (reported)Study Completion
August 2015
Actual (reported)Last Updated
November 2, 2022
Results First Posted
April 9, 2018
Record last verified: 2022-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: